Nasara, Aiza .
HRN: 15-11-29 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2025
CEFTRIAXONE 1G (VIAL)
11/22/2025
11/24/2025
IV
2g
OD
CAP
Checking Initial Appropriateness
11/23/2025
CEFUROXIME 500MG (TAB)
11/23/2025
11/30/2025
ORAL
500mg
BID
THICKLY MSAF
Checking Initial Appropriateness
11/23/2025
METRONIDAZOLE 500MG (TAB)
11/23/2025
11/30/2025
ORAL
500mg
TID
Thickly MSAF
Checking Initial Appropriateness